Breaking News Instant updates and real-time market news.

ALNY

Alnylam

$70.30

1.73 (2.52%)

17:00
10/05/16
10/05
17:00
10/05/16
17:00

Alnylam resumed

  • 14

    Oct

  • 06

    Nov

ALNY Alnylam
$70.30

1.73 (2.52%)

08/22/16
WEDB
08/22/16
NO CHANGE
WEDB
Intellia Therapeutics data positive, says Wedbush
Wedbush analyst David Nierengarten says that additional data on Intella's (NTLA) TTR program in mice was "meaningful" and indicates that the program compares favorably with competing products. The analyst says that competing programs, including those of Alnylam (ALNY) and Ionis (IONS) have shown "only a transient benefit." He reiterates a $38 price target and Outperform rating on Intella.
09/09/16
LEER
09/09/16
NO CHANGE
LEER
Leerink updates therapeutics best ideas for 2016
In a note to investors this morning, Leerink has updated its best ideas for 2016 from the firm's five therapeutics analysts. The list includes Alexion (ALXN), Dermira (DERM), Intra-Cellular (ITCI), Sanofi (SNY), Allergan (AGN), Alnylam (ALNY), Innate Pharma (IPHYF), The Medicines Co. (MDCO), and Ophthotech (OPHT).
09/15/16
09/15/16
INITIATION
Target $82

Underperform
FBR calls Alexion overvalued, starts shares at Underperform
FBR Capital analyst Christopher James initiated coverage of Alexion Pharmaceuticals (ALXN) with an Underperform rating and $82 price target. The biotech focused on patients with ultra-rare disorders closed yesterday up $2.63 to $129.42. Alexion shares are overpriced as the company is facing a competitive near-term landscape, particularly from Alnylam's (ALNY) ALN-CC5, James tells investors in a research note. Further, near-term expansion into additional indications will be challenging given the recent failed study with eculizumab in refractory generalized myasthenia gravis, the analyst contends. He also sees possible pricing pressures from biosimilars, including an Amgen (AMGN) biosimilar product in development. James this morning also initiated Achillion Pharmaceuticals (ACHN) and Arena Pharmaceuticals (ARNA) with Outperform ratings.
09/28/16
JANY
09/28/16
INITIATION
Target $74
JANY
Neutral
Alnylam initiated with a Neutral at Janney Capital
Janney Capital analyst Roy Buchanan initiated Alnylam with a Neutral and a $74 fair value estimate. The analyst is not confident about the outcome for the pivotal study for patisiran in transthyretin familial amyloid neuropathy, expected in about 12 months, and give patisiran a 50% chance of success.

TODAY'S FREE FLY STORIES

DUST

Direxion Daily Gold Miners Bear 3X ETF

$20.92

-1.1 (-5.00%)

06:58
01/24/18
01/24
06:58
01/24/18
06:58
Technical Analysis
Direxion Daily Gold Miners Bear 3X ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CEVA

Ceva

$48.35

0.05 (0.10%)

06:58
01/24/18
01/24
06:58
01/24/18
06:58
Downgrade
Ceva rating change  »

Ceva downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

JDST

Direxion Daily Junior Gold Miners Index Bear 3x Shares

$46.38

-2.19 (-4.51%)

06:58
01/24/18
01/24
06:58
01/24/18
06:58
Technical Analysis
Daily Junior Gold Miners Index Bear 3x Shares: Pivot points, pivot low broken »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SGMS

Scientific Games

$54.85

-1 (-1.79%)

06:57
01/24/18
01/24
06:57
01/24/18
06:57
Earnings
Scientific Games sees Q4 revenue $820M-$825M, consensus $802.58M »

Scientific Games further…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VXX

iPath S&P 500 VIX Short-Term Futures

$26.69

0.44 (1.68%)

06:57
01/24/18
01/24
06:57
01/24/18
06:57
Technical Analysis
iPath S&P 500 VIX Short-Term Futures: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WTFC

Wintrust Financial

$88.04

0.54 (0.62%)

06:57
01/24/18
01/24
06:57
01/24/18
06:57
Recommendations
Wintrust Financial analyst commentary  »

Wintrust Financial price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMD

AMD

$12.94

0.29 (2.29%)

, MU

Micron

$43.95

1.07 (2.50%)

06:56
01/24/18
01/24
06:56
01/24/18
06:56
Periodicals
AMD taps former Nvidia, Synaptics execs for graphics chip division, VB reports »

Advanced Micro Devices…

AMD

AMD

$12.94

0.29 (2.29%)

MU

Micron

$43.95

1.07 (2.50%)

NVDA

Nvidia

$238.91

5.22 (2.23%)

SYNA

Synaptics

$44.90

-0.45 (-0.99%)

INTC

Intel

$46.06

0.31 (0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 25

    Jan

  • 30

    Jan

  • 07

    Feb

  • 26

    Mar

XIV

VelocityShares Daily Inverse VIX Short-Term ETN

$141.82

-2.88 (-1.99%)

06:56
01/24/18
01/24
06:56
01/24/18
06:56
Technical Analysis
VelocityShares Daily Inverse VIX Short-Term ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TVIX

VelocityShares Daily 2x VIX Short-Term ETN

$5.05

0.17 (3.48%)

06:56
01/24/18
01/24
06:56
01/24/18
06:56
Technical Analysis
VelocityShares Daily 2x VIX Short-Term ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMMU

Immunomedics

$18.11

0.96 (5.60%)

06:56
01/24/18
01/24
06:56
01/24/18
06:56
Recommendations
Immunomedics analyst commentary  »

Immunomedics price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SVXY

ProShares Short VIX Short-Term Futures

$133.48

-2.44 (-1.80%)

06:55
01/24/18
01/24
06:55
01/24/18
06:55
Technical Analysis
ProShares Short VIX Short-Term Futures: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USO

United States Oil Fund

$12.97

0.19 (1.49%)

06:55
01/24/18
01/24
06:55
01/24/18
06:55
Technical Analysis
United States Oil Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOP

SPDR Oil Exploration and Production Fund

$39.85

0.16 (0.40%)

06:54
01/24/18
01/24
06:54
01/24/18
06:54
Technical Analysis
SPDR Oil Exploration and Production Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CWST

Casella Waste

$24.26

0.09 (0.37%)

06:54
01/24/18
01/24
06:54
01/24/18
06:54
Upgrade
Casella Waste rating change  »

Casella Waste upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGAZ

VelocityShares 3x Inv Natural Gas ETN

$20.44

-2.99 (-12.76%)

06:54
01/24/18
01/24
06:54
01/24/18
06:54
Technical Analysis
VelocityShares 3x Inv Natural Gas ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UGAZ

VelocityShares 3x Long Natural Gas ETN

$89.75

10.55 (13.32%)

06:53
01/24/18
01/24
06:53
01/24/18
06:53
Technical Analysis
VelocityShares 3x Long Natural Gas ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EWZ

MSCI Brazil Index

$43.66

-0.97 (-2.17%)

06:52
01/24/18
01/24
06:52
01/24/18
06:52
Technical Analysis
MSCI Brazil Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EFA

iShares MSCI EAFE Index Fund

$74.75

0.24 (0.32%)

06:51
01/24/18
01/24
06:51
01/24/18
06:51
Technical Analysis
iShares MSCI EAFE Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USAP

Universal Stainless & Alloy

$22.85

0.44 (1.96%)

06:51
01/24/18
01/24
06:51
01/24/18
06:51
Earnings
Universal Stainless & Alloy reports Q4 EPS $1.06 with items vs. (22c) a year ago »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RES

RPC, Inc.

$25.13

-0.28 (-1.10%)

06:50
01/24/18
01/24
06:50
01/24/18
06:50
Hot Stocks
RPC, Inc. raises quarterly dividend by 43% to 10c per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 15

    May

BHGE

Baker Hughes

$35.82

0.27 (0.76%)

06:49
01/24/18
01/24
06:49
01/24/18
06:49
Hot Stocks
Baker Hughes CEO: Continue to see improvement in activity »

Lorenzo Simonelli, BHGE…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RES

RPC, Inc.

$25.13

-0.28 (-1.10%)

06:49
01/24/18
01/24
06:49
01/24/18
06:49
Earnings
RPC, Inc. reports Q4 adjusted EPS 27c, consensus 34c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 15

    May

PBYI

Puma Biotechnology

$90.90

-3.05 (-3.25%)

06:49
01/24/18
01/24
06:49
01/24/18
06:49
Downgrade
Puma Biotechnology rating change  »

Cowen downgrades Puma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNK

SPDR Barclays High Yield Bond

$36.96

0.11 (0.30%)

06:49
01/24/18
01/24
06:49
01/24/18
06:49
Technical Analysis
SPDR Barclays High Yield Bond: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HZO

MarineMax

06:49
01/24/18
01/24
06:49
01/24/18
06:49
Earnings
Breaking Earnings news story on MarineMax »

MarineMax raises FY18 EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.